Advances In Biobetters In Key Markets - Opportunities For Biotechnology Companies To Sustain Innovation With Low Risk And High Value OfferingsGBI Research, the leading business intelligence provider, has released its latest research on, “Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings”, which provides insights into the impact of biobetter therapies on the top selling biologic therapeutics, the regulatory procedure surrounding entry in the biobetters market and including recent technological advances that have driven advancement in the market. The report provides an in-depth analysis of top selling biobetter products covering top selling protein classes, erythropoietin’s, granulocyte-colony stimulating factors (G-CSF), interferon-α, interferon-beta, insulin and insulin analogs, monoclonal antibodies (mAbs) and tumor Necrosis Factor-α (TNF-α). The report also includes insights into the biobetter therapeutics R&D pipeline. It analyzes the competitive landscape, including Mergers and Acquisitions (M&As), and licensing and co-development deals.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Get Sample Copy Of Report: http://www.marketresearchreports.biz/sample/sample/125694
GBI Research found that on average biobetter launches generate more revenues than their corresponding originator therapies. In some scenarios this extended to, the launch of a biobetter therapy substituting the sales from an existing originator product or biobetter therapy.
Data and analysis on the impact of biobetter therapeutics on the major top selling biologics erythropoietin’s, granulocyte-colony stimulating factors (G-CSF), interferon-α, interferon-beta, insulin and insulin analogs, human growth hormone and monoclonal and mAbs.
Pipeline analysis of biobetter therapies in major protein classes erythropoietin’s, G-CSF, interferon-α, interferon-beta, insulin and insulin analogs, mAbs and TNF-α.
Key drivers and restraints that have had a significant impact on the market.
The competitive landscape of the global biobetter therapeutics market, including companies such as Celgene, Amgen, Bristol-Myers Squibb, Amylin and Dainippon Sumitomo Pharma.
Key M&A activities and licensing and co-development agreements that took place from 2010-2012 in the global Biobetters market.
Reasons to buy
Align your product portfolio to the markets with high growth potential.
Develop business strategies by understanding the trends shaping and driving technological advancements in the field of biobetter therapies.
Identify key molecules in development being used for biobetter therapies.
Reinforce R&D pipelines by identifying common drug class biobetters in the pipeline for top selling protein classes.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
MarketResearchReports.biz supports your business intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market data sheets in its repository. Our document database is updated by the hour, which means that you always have access to fresh data spanning over 300 industries and their sub-segments.
90 State Street, Suite 700
Albany, NY 12207
Toll Free: 866-997-4948
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advances In Biobetters In Key Markets - Opportunities For Biotechnology Companies To Sustain Innovation With Low Risk And High Value Offerings here
News-ID: 378074 • Views: …
More Releases from BIZ COM
Takeaway Food Delivery Market: Focus On Online Channel (2014-19) Will offers a c …
Scope of the Report View Full Report: http://www.marketresearchreports.biz/analysis/211594 The Report titled “Takeaway Food Delivery Market: Focus on Online Channel (2014-2019)” provides an insight into takeaway Food Delivery market with a special focus on online takeaway food. The report also includes the market value, segmentation and also country-wise market analysis. It also discusses key growth drivers, challenges and upcoming trends of the market. Further, companies like Just Eat, GrubHub, Delivery Hero, and Takeaway.com
More Releases for GBI
Cancer vaccines market will soar to $7.5 billion by 2022, says GBI Research
The cancer vaccines market is set to almost triple from $2.5 billion in 2015 to $7.5 billion by 2022, representing a strong compound annual growth rate of 16.93%. Adam Bradbury, Associate Analyst for GBI Research, explains: “The cancer vaccines space will see such impressive growth over next decade for a number of reasons. There is a fairly large cancer vaccine pipeline, with over 1,200 products being developed, accounting for almost 17%
GBI: Top Ten Clean Technology Trends in 2011 on reports-research.com
GBI Research's new report, Top Ten Clean Technology Trends in 2011 provides key information and detailed insight into clean technology industry trends. It contains a detailed analysis on the major trends in various domains of the clean technology sector. It discusses the emergence of Lithium-ion and Nickel-metal Hydride battery technology in the advanced battery segment. The report analyses the impact of government regulations in the water and wastewater management industry,
GBI: Manufacturing of Biologics on reports-research.com
GBI Research's report, Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies, provides the key data and analyzes the major challenges and drivers for the bio-manufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of
GBI: Power Management Integrated Circuits (IC) Market to 2020 on reports-researc …
GBI Research’s Semi-conductor’s report, Power Management Integrated Circuits (IC) Market to 2020 - Battery Powered Portable Gadgets to Drive Sales Growth provides the key market statistics and analysis on the Power Management IC industry. The report covers the key market drivers, restraints and growth forecasts for the major segments in the Power Management Industry. Rapid adoption of smart phones is expected to boost the demand of Power Management ICs. The
GBI: Smart Grid Market Analysis and Forecasts to 2020 on reports-research.com
The report provides analysis of the Global Smart Grid Market and Forecasts for the four major geographical regions up to 2020. The research analyzes the state of smart grid deployments in the four major geographical regions and it future potential up to 2020. The research also provides the historical and forecast of revenues for four different smart grid technologies including smart meters, broadband over power line, HVDC and energy storage. Government
GBI: Power Market in Eastern Europe to 2020 on reports-research.com
GBI Research has released its power report Power Market in Eastern Europe to 2020: New Investments to Drive Power Demand in the Region. The report gives an in-depth analysis of the top 10 Eastern Europe power markets, (Russia, Lithuania, Bulgaria, Slovakia, Poland, Hungary, Romania, Croatia, Czech Republic and Ukraine). The research analyzes the regulatory framework and infrastructure of the power sector in these 10 countries. It provides a detailed forecast